N | n | % (95% CI) | Univariate Odds Ratio (95% CI) | P | Multivariate Odds Ratio (95% CI) | P | |
---|---|---|---|---|---|---|---|
Age, y | <0.001 | <0.001 | |||||
60–69 | 402 | 37 | 9.20 (6.38–12.03) | 1 | 1 | ||
70–79 | 171 | 37 | 21.64 (15.47–27.81) | 2.72 (1.66–4.48)‡ | <0.001 | 3.28 (1.78–6.07)‡ | <0.001 |
80~ | 76 | 25 | 32.89 (22.33–43.46) | 4.84 (2.69–8.69)‡ | <0.001 | 3.93 (1.85–8.35)‡ | <0.001 |
Total | 649 | 99 | 15.25 (12.49–18.02) | ||||
Age adjusted† | 16.63 (13.76–19.49) | ||||||
Gender | 0.026 | 0.044 | |||||
Male | 263 | 30 | 11.41 (7.56–15.25) | 1 | 1 | ||
Female | 386 | 69 | 17.88 (14.05–21.70) | 1.69 (1.07–2.68)* | 1.79 (1.02–3.15)* | ||
Occupation | 0.156 | 0.049 | |||||
Farmer | 111 | 18 | 16.22 (9.36–23.07) | 1 | 1 | ||
Non-farmer | 538 | 135 | 25.09 (21.43–28.76) | 1.59 (0.84–3.02) | 2.17 (1.01–4.68)* | ||
Level of education | 0.083 | 0.226 | |||||
Illiteracy | 85 | 15 | 17.65 (9.54–25.75) | 1 | 1 | ||
Primary school | 308 | 55 | 17.86 (13.58–22.13) | 1.01 (0.54–1.90) | 0.964 | 1.79 (0.80–4.01) | 0.156 |
Secondary school or higher | 256 | 29 | 11.33 (7.45–15.21) | 0.60 (0.30–1.18) | 0.135 | 1.25 (0.50–3.09) | 0.637 |
Insurance status | 0.923 | 0.779 | |||||
No | 6 | 1 | 16.67 (−13.15–46.49) | 1 | 1 | ||
Yes | 643 | 98 | 15.24 (12.46–18.02) | 0.90 (0.10–7.78) | 0.72 (0.05–10.05) | ||
Refractive error | <0.0001 | <0.001 | |||||
Emmetropia | 156 | 12 | 7.69 (3.51–11.87) | 1 | 1 | ||
Hyperopia | 228 | 25 | 10.96 (6.91–15.02) | 1.50 (0.73–3.08) | 0.271 | 1.62 (0.73–3.59) | 0.234 |
Low myopia | 168 | 31 | 18.45 (12.59–24.32) | 2.72 (1.34–5.50)† | 0.005 | 2.99 (1.36–6.55)† | 0.006 |
Moderate myopia | 53 | 14 | 24.62 (14.55–38.28) | 4.60 (1.97–10.78)† | 0.001 | 11.45 (3.86–33.92)‡ | <0.001 |
High myopia | 44 | 17 | 38.64 (24.25–53.02) | 7.66 (3.29–17.84)‡ | <0.0001 | 18.91 (5.97–59.92)‡ | <0.001 |
Lens status | <0.0001 | 0.001 | |||||
Normal | 270 | 18 | 6.67 (3.69–9.64) | 1 | 1 | ||
Opacities | 379 | 81 | 21.37 (17.24–25.50) | 3.81 (2.22–6.51)‡ | 2.83 (1.50–5.36)† | ||
Diabetic retinopathy | 0.026 | 0.035 | |||||
No | 619 | 90 | 14.54 (11.76–17.32) | 1 | 1 | ||
Yes | 30 | 9 | 30.00 (13.60–46.40) | 2.52 (1.12–5.68)* | 2.99 (1.08–8.30)* | ||
Combined with other retinal diseases | 0.045 | 0.995 | |||||
No | 597 | 86 | 14.41 (11.59–17.22) | 1 | 1 | ||
Yes | 52 | 13 | 25.00 (13.23–36.77) | 1.98 (1.02–3.86)* | 1.00 (0.40–2.48) | ||
Duration of diabetes (y) | 0.279 | 0.223 | |||||
< 5 | 303 | 52 | 17.16 (12.92–21.41) | 1 | 1 | ||
5–10 | 212 | 24 | 11.32 (7.06–15.59) | 0.62 (0.37–1.04) | 0.068 | 0.60 (0.33–1.10) | 0.100 |
10–15 | 80 | 13 | 16.25 (8.17–24.33) | 0.94 (0.48–1.82) | 0.847 | 0.56(0.25–1.28) | 0.172 |
≥ 15 | 54 | 10 | 18.52 (8.16–28.88) | 1.10 (0.52–2.32) | 0.808 | 0.50 (0.19–1.27) | 0.145 |
Drug use for diabetes | 0.279 | 0.401 | |||||
No | 89 | 17 | 19.10 (10.93–27.27) | 1 | 1 | ||
Yes | 560 | 82 | 14.64 (11.71–17.57) | 0.73 (0.41–1.30) | 0.73 (0.36–1.51) | ||
History of diabetic retinopathy therapy | 0.053 | 0.205 | |||||
No | 630 | 93 | 14.76 (11.99–17.53) | 1 | 1 | ||
Yes | 19 | 6 | 31.58 (10.68–52.48) | 2.67 (1.00–7.19) | 2.36 (0.63–8.90) | ||
HbA1c (g%) | <0.001 | 0.003 | |||||
< 5.6 | 70 | 7 | 10.00 (2.97–17.03) | 1 | 1 | ||
5.6–7.0 | 260 | 31 | 11.92 (7.98–15.86) | 1.22 (0.51–2.90) | 0.655 | 0.74 (0.28–1.96) | 0.546 |
7.1–8.0 | 138 | 18 | 13.04 (7.42–18.66) | 1.35 (0.54–3.40) | 0.525 | 0.85 (0.30–2.43) | 0.765 |
8.1–10.0 | 105 | 18 | 17.14 (9.93–24.35) | 1.86 (0.73–4.73) | 0.191 | 1.21 (0.43–3.41) | 0.721 |
≥ 10.0 | 76 | 25 | 32.89 (22.33–43.46) | 4.41 (1.77–11.02)† | 0.001 | 3.18 (1.11–9.12)* | 0.031 |
BMI(kg/m2) | 0.211 | 0.096 | |||||
Normal | 299 | 42 | 14.05 (10.11–17.99) | 1 | 1 | ||
Lean | 28 | 8 | 28.57 (11.84–45.30) | 2.45 (1.01–5.92)* | 0.047 | 3.44 (1.19–9.91)* | 0.022 |
Overweight | 268 | 39 | 14.55 (10.33–18.77) | 1.04 (0.65–1.67) | 0.864 | 1.07 (0.61–1.90) | 0.810 |
Obese | 54 | 10 | 18.52 (8.16–28.88) | 1.39 (0.65–2.97) | 0.395 | 1.74 (0.69–4.39) | 0.244 |
Hypertension | 0.325 | 0.894 | |||||
No | 245 | 33 | 13.47 (9.19–17.74) | 1 | 1 | ||
Yes | 404 | 66 | 16.34 (12.73–19.94) | 1.25 (0.80–1.97) | 0.96 (0.55–1.69) | ||
Hyperlipidaemia | 0.620 | 0.577 | |||||
No | 631 | 97 | 15.37 (12.56–18.19) | 1 | 1 | ||
Yes | 18 | 2 | 11.11 (−3.41–25.63) | 0.69 (0.16–3.04) | 0.61 (0.11–3.42) | ||
Smoker | 0.780 | 0.529 | |||||
No | 531 | 82 | 15.44 (12.37–18.52) | 1 | 1 | ||
Yes | 118 | 17 | 14.41 (8.07–20.74) | 0.92 (0.52–1.62) | 0.67 (0.19–2.37) | ||
Alcohol use | 0.791 | 0.715 | |||||
No | 537 | 81 | 15.08 (12.06–18.11) | 1 | 1 | ||
Yes | 112 | 18 | 16.07 (9.27–22.87) | 1.08 (0.62–1.88) | 1.26 (0.36–4.38) | ||
Cardiovascular disease | 0.487 | 0.832 | |||||
No | 595 | 89 | 14.96 (12.09–17.82) | 1 | 1 | ||
Yes | 54 | 10 | 18.52 (8.16–28.88) | 1.29 (0.63–2.66) | 1.10 (0.44–2.74) | ||
Distance eyeglasses wearing | 0.703 | 0.011 | |||||
No | 525 | 79 | 15.05 (11.99–18.11) | 1 | 1 | ||
Yes | 124 | 20 | 16.13 (9.66–22.60) | 1.09 (0.64–1.85) | 0.34 (0.15–0.78)* |